scPharmaceuticals Inc (SCPH)
4.83
+0.16
(+3.43%)
USD |
NASDAQ |
May 03, 09:47
scPharmaceuticals Profit Margin (Quarterly): -226.6% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -226.6% |
September 30, 2023 | -411.9% |
Date | Value |
---|---|
June 30, 2023 | -864.1% |
March 31, 2023 | -543.4% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-864.1%
Minimum
Jun 2023
-226.6%
Maximum
Dec 2023
-511.5%
Average
-477.6%
Median
Profit Margin (Quarterly) Benchmarks
Anika Therapeutics Inc | -146.6% |
Spero Therapeutics Inc | 71.27% |
electroCore Inc | -77.67% |
NovaBay Pharmaceuticals Inc | -110.2% |
Palatin Technologies Inc | -385.6% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -91.95% |
Return on Assets | -49.59% |
Return on Invested Capital | -58.05% |
Gross Profit Margin (Quarterly) | 70.92% |
Operating Margin (Quarterly) | -250.3% |
Return on Net Operating Assets | -428.3% |